ASCEND-2: a canary in a coal mine for descending to second-line treatment for ALK-rearranged non-small cell lung cancer

Transl Lung Cancer Res. 2016 Dec;5(6):660-664. doi: 10.21037/tlcr.2016.12.01.

Authors

Viola W Zhu¹, Sai-Hong Ignatius Ou²

Affiliations

¹ Division of Hematology/Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California, Irvine School of Medicine, Orange, CA 92868, USA; ; Hematology/Oncology Section, VA Long Beach Healthcare System, Long Beach, CA 90822, USA.
² Division of Hematology/Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California, Irvine School of Medicine, Orange, CA 92868, USA.

No abstract available

Publication types

Editorial
Comment